Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-090224
Filing Date
2016-01-06
Accepted
2016-01-06 21:07:00
Documents
1
Period of Report
2016-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4043
  Complete submission text file 0001209191-16-090224.txt   5615
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Issuer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12390 EL CAMINO REAL #150 SAN DIEGO CA 92130
Business Address
Roberts Brandi (Reporting) CIK: 0001516354 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32157 | Film No.: 161328668